4.7 Article

Nuclear reprogramming

期刊

DEVELOPMENT
卷 140, 期 12, 页码 2468-2471

出版社

COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/dev.092049

关键词

Transdifferentiation; Cell fusion; Induced pluripotency; Nuclear transfer; Pluripotent; Reprogramming

资金

  1. Medical Research Council
  2. Wellcome Trust
  3. California Institute for Regenerative Medicine training grant
  4. MRC [G1001690] Funding Source: UKRI
  5. Biotechnology and Biological Sciences Research Council [BBS/B/14647] Funding Source: researchfish
  6. Medical Research Council [G1001690] Funding Source: researchfish
  7. Wellcome Trust [101050/Z/13/Z] Funding Source: researchfish
  8. Wellcome Trust [101050/Z/13/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

There is currently particular interest in the field of nuclear reprogramming, a process by which the identity of specialised cells may be changed, typically to an embryonic-like state. Reprogramming procedures provide insight into many mechanisms of fundamental cell biology and have several promising applications, most notably in healthcare through the development of human disease models and patient-specific tissue-replacement therapies. Here, we introduce the field of nuclear reprogramming and briefly discuss six of the procedures by which reprogramming may be experimentally performed: nuclear transfer to eggs or oocytes, cell fusion, extract treatment, direct reprogramming to pluripotency and transdifferentiation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据